Barrier maintenance by S1P during inflammation and sepsis

Tissue Barriers. 2021 Oct 2;9(4):1940069. doi: 10.1080/21688370.2021.1940069. Epub 2021 Jun 21.

Abstract

Sphingosine 1-phosphate (S1P) is a multifaceted lipid signaling molecule that activates five specific G protein-coupled S1P receptors. Despite the fact that S1P is known as one of the strongest barrier-enhancing molecules for two decades, no medical application is available yet. The reason for this lack of translation into clinical practice may be the complex regulatory network of S1P signaling, metabolism and transportation.In this review, we will provide an overview about the physiology and the network of S1P signaling with the focus on endothelial barrier maintenance in inflammation. We briefly describe the physiological role of S1P and the underlying S1P signaling in barrier maintenance, outline differences of S1P signaling and metabolism in inflammatory diseases, discuss potential targets and compounds for medical intervention, and summarize our current knowledge regarding the role of S1P in the maintenance of specialized barriers like the blood-brain barrier and the placenta.

Keywords: Endothelial cell; S1P lyase; S1P receptor; apolipoprotein M; sphingosine 1-phosphate; sphingosine kinase.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Inflammation / metabolism
  • Lysophospholipids* / metabolism
  • Sepsis*
  • Sphingosine / analogs & derivatives
  • Sphingosine / metabolism

Substances

  • Lysophospholipids
  • sphingosine 1-phosphate
  • Sphingosine

Grants and funding

This work was supported by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) within the Center for Sepsis Control and Care (CSCC) and the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) within the RTG 1715.